126 related articles for article (PubMed ID: 38127416)
1. Targeting CDK6 in hormone receptor-positive breast cancer: inhibitor discovery for precision oncology through dynamics study.
Khatoon Z; Khalid M; Alqarni MH; Foudah AI; Annadurai S; Wahab S; Abdullah Almoyad MA
J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38127416
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches.
Luo X; Zhao Y; Tang P; Du X; Li F; Wang Q; Li R; He J
Mol Divers; 2021 Feb; 25(1):367-382. PubMed ID: 32770459
[TBL] [Abstract][Full Text] [Related]
3. Controlling cell proliferation by targeting cyclin-dependent kinase 6 using drug repurposing approach.
Madhana Priya N; Balasundaram A; Sidharth Kumar N; Udhaya Kumar S; Thirumal Kumar D; Magesh R; Zayed H; George Priya Doss C
Adv Protein Chem Struct Biol; 2023; 135():97-124. PubMed ID: 37061342
[TBL] [Abstract][Full Text] [Related]
4. Predictive hybrid paradigm for cytotoxic activity of 1,3,4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural modifications: rational for novel cancer therapeutics.
Chukwuemeka PO; Umar HI; Iwaloye O; Oretade OM; Olowosoke CB; Oretade OJ; Elabiyi MO
J Biomol Struct Dyn; 2022 Nov; 40(18):8518-8537. PubMed ID: 33890551
[TBL] [Abstract][Full Text] [Related]
5. Computational exploration of allosteric inhibitors targeting CDK4/CDK6 proteins: a promising approach for multi-target drug development.
Khan M; Singh K; Khan S; Ahmad B; Khushal A; Yingning S
J Biomol Struct Dyn; 2024 Jan; ():1-19. PubMed ID: 38174658
[TBL] [Abstract][Full Text] [Related]
6. CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.
Tigan AS; Bellutti F; Kollmann K; Tebb G; Sexl V
Oncogene; 2016 Jun; 35(24):3083-91. PubMed ID: 26500059
[TBL] [Abstract][Full Text] [Related]
7. Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6.
Yousuf M; Shamsi A; Khan P; Shahbaaz M; AlAjmi MF; Hussain A; Hassan GM; Islam A; Rizwanul Haque QM; Hassan MI
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429317
[TBL] [Abstract][Full Text] [Related]
8. A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations.
Susanti NMP; Damayanti S; Kartasasmita RE; Tjahjono DH
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948218
[TBL] [Abstract][Full Text] [Related]
9. Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
Yousif FA; Alzain AA; Alraih AM; Ibraheem W
PLoS One; 2023; 18(9):e0291256. PubMed ID: 37682937
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of hsa_circ_0136666 contributes to breast cancer progression by sponging miR-1299 and targeting CDK6.
Liu LH; Tian QQ; Liu J; Zhou Y; Yong H
J Cell Biochem; 2019 Aug; 120(8):12684-12693. PubMed ID: 30993801
[TBL] [Abstract][Full Text] [Related]
11. High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor-Positive Metastatic Breast Cancer.
Alves CL; Elias D; Lyng M; Bak M; Kirkegaard T; Lykkesfeldt AE; Ditzel HJ
Clin Cancer Res; 2016 Nov; 22(22):5514-5526. PubMed ID: 27252418
[TBL] [Abstract][Full Text] [Related]
12. Targeting cyclin-dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies.
Yousuf M; Shamsi A; Queen A; Shahbaaz M; Khan P; Hussain A; Alajmi MF; Rizwanul Haque QM; Imtaiyaz Hassan M
J Cell Biochem; 2021 Aug; 122(8):897-910. PubMed ID: 33829554
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy.
Yousuf M; Khan P; Shamsi A; Shahbaaz M; Hasan GM; Haque QMR; Christoffels A; Islam A; Hassan MI
ACS Omega; 2020 Oct; 5(42):27480-27491. PubMed ID: 33134711
[TBL] [Abstract][Full Text] [Related]
14. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy.
Hassan MI; Anjum D; Mohammad T; Alam M; Khan MS; Shahwan M; Shamsi A; Yadav DK
J Biomol Struct Dyn; 2023 Dec; 41(20):10558-10568. PubMed ID: 36495308
[TBL] [Abstract][Full Text] [Related]
15. Functional Genomic Analysis of CDK4 and CDK6 Gene Dependency across Human Cancer Cell Lines.
Zhang Z; Golomb L; Meyerson M
Cancer Res; 2022 Jun; 82(11):2171-2184. PubMed ID: 35395071
[TBL] [Abstract][Full Text] [Related]
16. Investigating the Mechanism of Inhibition of Cyclin-Dependent Kinase 6 Inhibitory Potential by Selonsertib: Newer Insights Into Drug Repurposing.
Baig MH; Yousuf M; Khan MI; Khan I; Ahmad I; Alshahrani MY; Hassan MI; Dong JJ
Front Oncol; 2022; 12():865454. PubMed ID: 35720007
[TBL] [Abstract][Full Text] [Related]
17. A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis.
Kollmann K; Heller G; Schneckenleithner C; Warsch W; Scheicher R; Ott RG; Schäfer M; Fajmann S; Schlederer M; Schiefer AI; Reichart U; Mayerhofer M; Hoeller C; Zöchbauer-Müller S; Kerjaschki D; Bock C; Kenner L; Hoefler G; Freissmuth M; Green AR; Moriggl R; Busslinger M; Malumbres M; Sexl V
Cancer Cell; 2013 Aug; 24(2):167-81. PubMed ID: 23948297
[TBL] [Abstract][Full Text] [Related]
18. A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9.
Atiya A; Shahidi H; Mohammad T; Sharaf SE; Abdulmonem WA; Ashraf GM; Elasbali AM; Alharethi SH; Alhumaydhi FA; Baeesa SS; Rehan M; Shamsi A; Shahwan M
J Biomol Struct Dyn; 2023 Nov; 41(19):10202-10213. PubMed ID: 36562191
[TBL] [Abstract][Full Text] [Related]
19. Desmodin and isopongachromene as potential inhibitors of cyclin-dependent kinase 5: phytoconstituents targeting anticancer and neurological therapy.
Atiya A; Batra S; Mohammad T; Alorfi NM; Abdulmonem WA; Alhumaydhi FA; Ashraf GM; Baeesa SS; Elasbali AM; Shahwan M
J Biomol Struct Dyn; 2023; 41(16):8042-8052. PubMed ID: 36184739
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells.
Whiteway SL; Harris PS; Venkataraman S; Alimova I; Birks DK; Donson AM; Foreman NK; Vibhakar R
J Neurooncol; 2013 Jan; 111(2):113-21. PubMed ID: 23138228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
